Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...
The Chosun Ilbo on MSN
KAIST unveils B-cell targeting AI cancer vaccine
The fear of cancer stems from the dread that it can recur at any time, even after treatment. A South Korean research team has unveiled a new personalized cancer vaccine technology that enables the ...
B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments in ...
There are currently ~38 million people worldwide living with HIV. If left untreated, HIV infection progresses to acquired immunodeficiency syndrome (AIDS) where patients become extremely vulnerable to ...
Emirates News Agency on MSN
Korean team develops AI model for 'customised' cancer vaccine
A joint research team from the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm Neogenlogic has developed a new artificial intelligence (AI) model designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback